8/24 Net revenue for the first fiscal quarter of 2008 was $62.4 million, an increase of 71% compared to net revenue of $36.4 million for the same quarter last year and a 15% increase compared to net revenue of $54.5 million in the prior quarter. Brian NeSmith, President and Chief Executive Officer. "Clearly our customers see the value in our unique ability to provide security and high speed application delivery in one appliance, our ProxySG(R) product. 50M Cash, Zero LT Liab. Strong growth in cash flow. TECH is a strong sector going forward 84.99 8/24 close; 8/27 Open 84.66; 8/28 Open $84.02; 8/29 open/sell 82.43 Net -0.75% (1 day) w/ NASDQ down 2.37% Net -2.6% Final (2 day) NASDQ up 2.8% Final Analysis. This stock has run up 400% in the last year or so. Investors cite the high multiple as a negative...maybe overpriced? Profit taking might be occurring on price increases/high volume...

8/28 (VOL 710%) Omrix Biopharmaceuticals, Inc.. The Groups' principal activities are to develop and market innovative biological products. It is a commercial-stage biopharmaceutical company. The Group utilizes proprietary protein purification technology and manufacturing know-how to develop biosurgical and passive immunotherapy products. *Received FDA approval on product today* 83.7M Cash; Zero LTD Missed earnings last 2 consecutive qtrs. P/E forward 28% on lower earnings expectations/SP500 20% Earnings Surprise? Short float 13%...look for covering to squeeze price higher? 33.96 8/28 close; 8/29 Open 34.38; 8/30 Open 34.13; 8/31 open/sell Net -0.1% (1 Day) Nasdq up 2.8% Net (2 Day) NASDQ down 0.1%

8/24 Small-Cap Company focuses on military and industrial advanced communications products. It missed its 2nd qtr earning consensus but has a ramping business in military communications. Order backlogs and steady revenue growth are appealing. $7.6 cash/sh Possible new contract in pipeline? 24.02 8/24 close; 8/27 Open 24.10; 8/28 Open $24.77; 8/29 Open/Sell 25.08 Net 2.8% (1 Day) NASDQ down 2.37% Final Net 4.1% (2 Day) NASDQ up 2.8% Final Analysis. Good Trade on fundamentals, non-cyclical sector. Company appears to have a niche between communications and military/defense.